Literature DB >> 8923535

Induction of glucose-regulated protein (glucose-regulated protein 78/BiP and glucose-regulated protein 94) and heat shock protein 70 transcripts in the immature rat brain following status epilepticus.

E Little1, G Tocco, M Baudry, A S Lee, S S Schreiber.   

Abstract

Prior to 21 days of age, the immature rat brain is relatively resistant to excitotoxicity caused by the glutamate analogue, kainate. As stress-inducible proteins (GRP78, GRP94 and HSP70) have been proposed to possess molecular chaperone activity and protect cells from the deleterious effects of damaged proteins, we examined the pattern of expression of their respective messenger RNAs following systemic kainate at different postnatal ages. In untreated rats between seven and 21 days old, there was a higher basal level of grp78 and grp94 expression compared to hsp70. Unlike hsp70, which was inducible only in 21-day-old rats, kainate-mediated grp94 induction occurred in several regions of the brain as early as postnatal day 7. Grp78 messenger RNA expression was also increased by kainate treatment in 14-day-old rats, and the induction was most pronounced in the kainate-resistant dentate gyrus. With increasing age, longer lasting expression of both grp78 and grp94 messenger RNAs was observed in kainate-vulnerable regions, similar to observations in the adult rat brain. These results demonstrate non-overlapping expression patterns of glucose-regulated proteins and HSP70 in the immature central nervous system, suggesting that they serve different functions. While hsp70 induction could be a marker for potential cell injury and death, increased expression of grp78 and grp94 could play a neuroprotective role in the developing rat brain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923535     DOI: 10.1016/0306-4522(96)00267-9

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

Review 1.  Orchestrating the unfolded protein response in health and disease.

Authors:  Randal J Kaufman
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

2.  Role of endoplasmic reticulum stress via the PERK signaling pathway in brain injury from status epilepticus.

Authors:  Jing Chen; Guo Zheng; Hu Guo; Zhong-Nan Shi
Journal:  J Mol Neurosci       Date:  2014-01-23       Impact factor: 3.444

3.  CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism.

Authors:  Robert M Silva; Vincent Ries; Tinmarla Frances Oo; Olga Yarygina; Vernice Jackson-Lewis; Elizabeth J Ryu; Phoebe D Lu; Stefan J Marciniak; David Ron; Serge Przedborski; Nikolai Kholodilov; Lloyd A Greene; Robert E Burke
Journal:  J Neurochem       Date:  2005-08-31       Impact factor: 5.372

Review 4.  Chaperones and proteases: cellular fold-controlling factors of proteins in neurodegenerative diseases and aging.

Authors:  Marie-Pierre Hinault; Anat Ben-Zvi; Pierre Goloubinoff
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

5.  Development-dependent regulation of molecular chaperones after hypoxia-ischemia.

Authors:  Xin Sun; Robert Crawford; Chunli Liu; Tianfei Luo; Bingren Hu
Journal:  Neurobiol Dis       Date:  2015-06-09       Impact factor: 5.996

6.  Assessment of ataxia phenotype in a new mouse model of galactose-1 phosphate uridylyltransferase (GALT) deficiency.

Authors:  Wyman Chen; Rose Caston; Bijina Balakrishnan; Anwer Siddiqi; Kamalpreet Parmar; Manshu Tang; Merry Feng; Kent Lai
Journal:  J Inherit Metab Dis       Date:  2016-10-25       Impact factor: 4.982

7.  Involvement of endoplasmic reticulum stress in a novel Classic Galactosemia model.

Authors:  Tatiana I Slepak; Manshu Tang; Vladlen Z Slepak; Kent Lai
Journal:  Mol Genet Metab       Date:  2007-07-20       Impact factor: 4.797

Review 8.  Rheumatoid arthritis as a hyper-endoplasmic-reticulum-associated degradation disease.

Authors:  Satoshi Yamasaki; Naoko Yagishita; Kaneyuki Tsuchimochi; Kusuki Nishioka; Toshihiro Nakajima
Journal:  Arthritis Res Ther       Date:  2005-08-17       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.